The humoral immune response to BCG vaccination

The humoral immune response to BCG vaccination

Bacillus Calmette Guérin (BCG) is the only currently available vaccine against tuberculosis (TB), but it confers incomplete and variable protection against pulmonary TB in humans and bovine TB (bTB) in cattle. Insights into the immune response induced by BCG offer an underexploited opportunity to ga...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Tanner, R, Villarreal-Ramos, B, Vordermeier, H, McShane, H
Natura:	Journal article
Pubblicazione:	Frontiers Media 2019

Documenti analoghi

Development of a BCG challenge model for the testing of vaccine candidates against tuberculosis in cattle
di: Villarreal-Ramos, B, et al.
Pubblicazione: (2017)

Comparison of the immunogenicity and protection against bovine tuberculosis following immunization by BCG-priming and boosting with adenovirus or protein based vaccines.
di: Dean, G, et al.
Pubblicazione: (2014)

Development of a BCG challenge model for the testing of vaccine candidates against tuberculosis in cattle.
di: Villarreal-Ramos, B, et al.
Pubblicazione: (2014)

Development of a BCG challenge model for the testing of vaccine candidates against tuberculosis in cattle
di: Villarreal-Ramos, B, et al.
Pubblicazione: (2014)

Comparison of the immunogenicity and protection against bovine tuberculosis following immunization by BCG-riming and boosting with adenovirus or protein based vaccines
di: Dean, G, et al.
Pubblicazione: (2014)

Evaluating the sensitivity of the bovine BCG challenge model using a prime boost Ad85A vaccine regimen
di: Biffar, L, et al.
Pubblicazione: (2019)

A mycobacterial growth inhibition assay (MGIA) for bovine TB vaccine development
di: Pepponi, I, et al.
Pubblicazione: (2017)

Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis.
di: Vordermeier, H, et al.
Pubblicazione: (2009)

Erratum: Viral booster vaccines improve mycobacterium bovis BCG-induced protection against bovine tuberculosis
di: Vordermeier, H, et al.
Pubblicazione: (2011)

Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate TB vaccine, MVA85A, alone and in combination
di: Harris, S, et al.
Pubblicazione: (2013)

A multi-antigenic adenoviral-vectored vaccine improves BCG-induced protection of goats against pulmonary tuberculosis infection and prevents disease progression
di: Pérez De Val, B, et al.
Pubblicazione: (2013)

Viral Booster Vaccines Improve Mycobacterium bovis BCG-Induced Protection against Bovine Tuberculosis, (vol 77, pg 3371, 2009)
di: Vordermeier, H, et al.
Pubblicazione: (2011)

Inflammation and immune activation are associated with risk of Mycobacterium tuberculosis infection in BCG-vaccinated infants
di: Satti, I, et al.
Pubblicazione: (2022)

T-cell activation is an immune correlate of risk in BCG vaccinated infants
di: Fletcher, H, et al.
Pubblicazione: (2016)

Revaccination with BCG: does it work?
di: McShane, H
Pubblicazione: (2024)

Understanding BCG is the key to improving it.
di: McShane, H
Pubblicazione: (2013)

Corrigendum: T-cell activation is an immune correlate of risk in BCG vaccinated infants.
di: Fletcher, H, et al.
Pubblicazione: (2016)

Vaccination against tuberculosis: how can we better BCG?
di: Pitt, J, et al.
Pubblicazione: (2013)

Vaccination against tuberculosis: How can we better BCG?
di: Pitt, J, et al.
Pubblicazione: (2013)

A Multi-Antigenic Adenoviral-Vectored Vaccine Improves BCG-Induced Protection of Goats against Pulmonary Tuberculosis Infection and Prevents Disease Progression
di: Perez de Val, B, et al.
Pubblicazione: (2013)

Editorial commentary: Understanding BCG is the key to improving it
di: McShane, H
Pubblicazione: (2014)

Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: comparison with boosting with a new TB vaccine, MVA85A.
di: Whelan, K, et al.
Pubblicazione: (2009)

Effect of dose and route of immunisation on the immune response induced in cattle by heterologous Bacille Calmette-Guerin priming and recombinant adenoviral vector boosting
di: Dean, G, et al.
Pubblicazione: (2014)

Effect of dose and route of immunisation on the immune response induced in cattle by heterologous Bacille Calmette-Guerin priming and recombinant adenoviral vector boosting.
di: Dean, G, et al.
Pubblicazione: (2014)

Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate tuberculosis vaccine, MVA85A, alone and in combination.
di: Harris, SA, et al.
Pubblicazione: (2014)

The Humoral Immune Response to HCV: Understanding is Key to Vaccine Development.
di: Cashman, S, et al.
Pubblicazione: (2014)

Preclinical development of an in vivo BCG challenge model for testing candidate TB vaccine efficacy.
di: Minassian, A, et al.
Pubblicazione: (2011)

Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses
di: Moon, James J., et al.
Pubblicazione: (2013)

Mycobacterium tuberculosis PPD-induced immune biomarkers measurable in vitro following BCG vaccination of UK adolescents by multiplex bead array and intracellular cytokine staining
di: Smith, S, et al.
Pubblicazione: (2010)

Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults
di: Pathan, A, et al.
Pubblicazione: (2012)

DEVELOPING A NEW TB VACCINE: BOOSTING BCG WITH MVA85A
di: Mcshane, H
Pubblicazione: (2008)

Replacing, reducing and refining the use of animals in tuberculosis vaccine 1 research
di: Tanner, R, et al.
Pubblicazione: (2016)

Humoral immune responses to adenovirus vectors in the brain.
di: Kajiwara, K, et al.
Pubblicazione: (2000)

BCG: Myths, realities, and the need for alternative vaccine strategies
di: Mcshane, H, et al.
Pubblicazione: (2012)

BCG: myths, realities, and the need for alternative vaccine strategies.
di: Mcshane, H, et al.
Pubblicazione: (2012)

A dose escalation study to evaluate the safety of an aerosol BCG infection in previously BCG-vaccinated healthy human UK adults
di: Fredsgaard-Jones, T, et al.
Pubblicazione: (2024)

Evaluating the effect of BCG vaccination on a whole-blood mycobacterial growth inhibition assay (BACTEC MGIT)
di: Tanner, R, et al.
Pubblicazione: (2011)

Humoral immune responses to Neisseria meningitidis in children.
di: Pollard, A, et al.
Pubblicazione: (1999)

Predicting IFN-γ responses after BCG vaccination in humans from macaques: A proof-of-concept study of Immunostimulation/Immunodynamic modelling methods
di: Rhodes, S, et al.
Pubblicazione: (2017)

Development of a non-human primate BCG infection model for the evaluation of candidate tuberculosis vaccines
di: Harris, S, et al.
Pubblicazione: (2017)